154 related articles for article (PubMed ID: 6339224)
1. Pathobiologic and metabolic aspects of mammary gland tumorigenesis by N-substituted aryl compounds.
Malejka-Giganti D; Ritter CL; Ryzewski CN
Environ Health Perspect; 1983 Mar; 49():175-83. PubMed ID: 6339224
[TBL] [Abstract][Full Text] [Related]
2. Activation of certain N-arylacetamides and N-arylacetohydroxamic acids in relation to mammary gland tumorigenesis in the rat.
Malejka-Giganti D
Natl Cancer Inst Monogr; 1981 Dec; (58):69-77. PubMed ID: 6804871
[TBL] [Abstract][Full Text] [Related]
3. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
Malejka-Giganti D; Rydell RE; Gutmann HR
Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
[TBL] [Abstract][Full Text] [Related]
4. Effect of ovariectomy on the in vitro and in vivo activation of carcinogenic N-2-fluorenylhydroxamic acids by rat mammary gland and liver.
Ritter CL; Bennett KK; Fullerton NF; Beland FA; Malejka-Giganti D
Carcinogenesis; 1996 Nov; 17(11):2411-8. PubMed ID: 8968056
[TBL] [Abstract][Full Text] [Related]
5. Microsomal metabolism of the carcinogen, N-2-fluorenyl-acetamide, by the mammary gland and liver of female rats. II. Glucuronidation of ring- and N-hydroxylated metabolites of N-2-fluorenylacetamide.
Malejka-Giganti D; Ryzewski CN
Carcinogenesis; 1985 May; 6(5):687-92. PubMed ID: 3924428
[TBL] [Abstract][Full Text] [Related]
6. Mixed function oxidase in the mammary gland and liver microsomes of lactating rats. Effects of 3-methylcholanthrene and beta-naphthoflavone.
Ritter CL; Malejka-Giganti D
Biochem Pharmacol; 1982 Jan; 31(2):239-47. PubMed ID: 6277340
[TBL] [Abstract][Full Text] [Related]
7. Free radicals in arylamine carcinogenesis.
Floyd RA
Natl Cancer Inst Monogr; 1981 Dec; (58):123-31. PubMed ID: 6281648
[TBL] [Abstract][Full Text] [Related]
8. Microsomal N- and C-oxidations of carcinogenic aromatic amines and amides.
Lotlikar PD; Hong YS
Natl Cancer Inst Monogr; 1981 Dec; (58):101-7. PubMed ID: 7341966
[TBL] [Abstract][Full Text] [Related]
9. Debenzoylating and deacetylating activities of rat liver and mammary gland microsomes. Effect of ovariectomy.
Ritter CL; Malejka-Giganti D
Biochem Pharmacol; 1995 Oct; 50(8):1265-72. PubMed ID: 7488243
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamide.
Malejka-Giganti D; McIver RC; Rydell RE
J Natl Cancer Inst; 1980 Jun; 64(6):1471-7. PubMed ID: 6929383
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome c/H2O2-mediated one electron oxidation of carcinogenic N-fluorenylacetohydroxamic acids to nitroxyl free radicals.
Ritter CL; Malejka-Giganti D; Polnaszek CF
Chem Biol Interact; 1983 Sep; 46(3):317-34. PubMed ID: 6315247
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone-mediated effects on the phase I and phase II metabolism of N-2-fluorenylacetamide. Modulation of 9-hydroxylation.
Malejka-Giganti D; Magat WJ; Decker RW
Biochem Pharmacol; 1989 Apr; 38(7):1075-82. PubMed ID: 2495797
[TBL] [Abstract][Full Text] [Related]
13. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
[TBL] [Abstract][Full Text] [Related]
14. Activation of the carcinogens N-hydroxy-N-2-fluorenylbenzamide and N-hydroxy-N-2-fluorenylacetamide via deacylations and acetyl transfers by rat peritoneal serosa and liver.
Ritter CL; Malejka-Giganti D
Carcinogenesis; 1994 Feb; 15(2):163-70. PubMed ID: 8313503
[TBL] [Abstract][Full Text] [Related]
15. N-hydroxylation of carcinogenic and mutagenic aromatic amines.
Kato R; Kamataki T; Yamazoe Y
Environ Health Perspect; 1983 Mar; 49():21-5. PubMed ID: 6832094
[TBL] [Abstract][Full Text] [Related]
16. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
Yost Y; Gutmann HR; Rydell RE
Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
[TBL] [Abstract][Full Text] [Related]
17. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
[TBL] [Abstract][Full Text] [Related]
18. Peroxidative metabolism of a carcinogen, N-hydroxy-N-2-fluorenylacetamide, by rat uterus and mammary gland in vitro.
Malejka-Giganti D; Ritter CL; Decker RW; Suilman JM
Cancer Res; 1986 Dec; 46(12 Pt 1):6200-6. PubMed ID: 3779640
[TBL] [Abstract][Full Text] [Related]
19. Relationship of metabolic activation of N-hydroxy-N-acylarylamines to biological response in the liver and mammary gland of the female CD rat.
Shirai T; Fysh JM; Lee MS; Vaught JB; King CM
Cancer Res; 1981 Nov; 41(11 Pt 1):4346-53. PubMed ID: 6118207
[TBL] [Abstract][Full Text] [Related]
20. Peroxidative metabolism of carcinogenic N-arylhydroxamic acids: implications for tumorigenesis.
Malejka-Giganti D; Ritter CL
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):75-81. PubMed ID: 7889863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
